Literature DB >> 12865307

Identification of a putative autocrine bone morphogenetic protein-signaling pathway in human ovarian surface epithelium and ovarian cancer cells.

Trevor G Shepherd1, Mark W Nachtigal.   

Abstract

Bone morphogenetic proteins (BMPs) are members of the TGFbeta superfamily of cytokines that are involved in development, differentiation, and disease. In an analysis of normal ovarian surface epithelium (OSE) and ovarian cancer (OC) cells, we observed BMP4 mRNA expression and found that primary OC cells produce mature BMP4. In addition, each member of the downstream signaling pathway was expressed in primary OSE and OC cells. Smad1 was phosphorylated and underwent nuclear translocation in normal OSE and OC cells upon treatment with BMP4. Interestingly, the BMP target genes ID1 and ID3 were up-regulated 10- to 15-fold in primary OC cells, compared with a 2- to 3-fold increase in normal OSE. The growth of several primary OC cells was relatively unaltered by BMP4 treatment; however, long-term BMP4 treatment of primary OC cells resulted in decreased cell density as well as increased cell spreading and adherence. These data demonstrate the existence and putative function of BMP signaling in normal OSE and OC cells, and thus the continued examination of BMP4 signaling in the regulation of these two processes will be critical to further our current understanding of the role of BMP biology in OC pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12865307     DOI: 10.1210/en.2003-0185

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

1.  Constitutive activation of BMP signalling abrogates experimental metastasis of OVCA429 cells via reduced cell adhesion.

Authors:  Trevor G Shepherd; Michelle L Mujoomdar; Mark W Nachtigal
Journal:  J Ovarian Res       Date:  2010-02-26       Impact factor: 4.234

2.  Inhibition of bone morphogenetic protein signaling reduces viability, growth and migratory potential of non-small cell lung carcinoma cells.

Authors:  Jelena Mihajlović; Laura A M Diehl; Andreas Hochhaus; Joachim H Clement
Journal:  J Cancer Res Clin Oncol       Date:  2019-09-17       Impact factor: 4.553

3.  Global gene expression analysis in time series following N-acetyl L-cysteine induced epithelial differentiation of human normal and cancer cells in vitro.

Authors:  Anna C Gustafsson; Ilya Kupershmidt; Esther Edlundh-Rose; Giulia Greco; Annalucia Serafino; Eva K Krasnowska; Thomas Lundeberg; Luisa Bracci-Laudiero; Maria-Concetta Romano; Tiziana Parasassi; Joakim Lundeberg
Journal:  BMC Cancer       Date:  2005-07-07       Impact factor: 4.430

4.  BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation.

Authors:  Teresa M Peart; Rohann J M Correa; Yudith Ramos Valdes; Gabriel E Dimattia; Trevor G Shepherd
Journal:  Clin Exp Metastasis       Date:  2012-01-17       Impact factor: 5.150

5.  Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation.

Authors:  Blanca Herrera; Maarten van Dinther; Peter Ten Dijke; Gareth J Inman
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

Review 6.  Ovary and fimbrial stem cells: biology, niche and cancer origins.

Authors:  Annie Ng; Nick Barker
Journal:  Nat Rev Mol Cell Biol       Date:  2015-09-09       Impact factor: 94.444

Review 7.  Regulation of bone morphogenetic protein 4 on epithelial tissue.

Authors:  Sitong Shen; Shurong Wang; Yuxi He; Huicong Hu; Boyuan Yao; Yan Zhang
Journal:  J Cell Commun Signal       Date:  2020-01-07       Impact factor: 5.782

Review 8.  Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.

Authors:  Pawina Jiramongkolchai; Philip Owens; Charles C Hong
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

9.  Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growth.

Authors:  Laura D Hover; Christian D Young; Neil E Bhola; Andrew J Wilson; Dineo Khabele; Charles C Hong; Harold L Moses; Philip Owens
Journal:  Cancer Lett       Date:  2015-07-30       Impact factor: 8.679

Review 10.  The Role of Bone Morphogenetic Protein 4 in Ovarian Function and Diseases.

Authors:  Dongyong Yang; Xiao Yang; Fangfang Dai; Yanqing Wang; Yi Yang; Min Hu; Yanxiang Cheng
Journal:  Reprod Sci       Date:  2021-05-08       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.